Figure 1
From: Repeated administration of alpha-galactosylceramide ameliorates experimental lupus nephritis in mice
The effects of repeated alpha-galactosylceramide (α-GalCer) administration on proteinuria and survival rates. (a) The levels of proteinuria in each group, measured 8 weeks after the last α-GalCer or vehicle injection (n = 5–7 in each group). *p < 0.05 compared with the vehicle group. (b) The percentages of mice with free of proteinuria and (c) the survival rate in the α-GalCer and the vehicle groups (n = 8 and 10, respectively). Arrows show the timing of when the mice were injected with α-GalCer or vehicle.
